NovaBone Products Receives 510(k) Clearance for Wound Dressing for the Advanced Wound Market

NovaBone Products has recently received FDA clearance for its innovative Wound Matrix product, making it the first of its kind in the wound care market. The Wound Matrix is a fully resorbable, sterile, and single-use device designed to manage various types of wounds, including partial and full-thickness wounds, ulcers, and surgical and trauma wounds.

“We are thrilled to obtain FDA clearance for Wound Matrix. This is our first product in the Advanced Wound Care market. Our core technology platforms of Bioactive glass and collagen combined with our manufacturing capability, uniquely position us to provide this differentiated product in the wound care space,” said Sameer Paranjpe, VP R&D and Operations at NovaBone.

Comprised of Type I bovine tendon collagen and bioactive glass, the device is a porous scaffold that can absorb fluids and become compressible once hydrated. NovaBone is excited about this advancement in the Advanced Wound Care market and is seeking commercial partners for distribution.

Read the full press release here.